HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

rV-Tricom

an intralesional vaccine for the treatment of malignant melanoma; in phase I clinical trial (11/2001)
Networked: 3 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Hesdorffer, Charles: 1 article (02/2006)
2. Schlom, Jeffrey: 1 article (02/2006)
3. DeRaffele, Gail: 1 article (02/2006)
4. Cheung, Ken: 1 article (02/2006)
5. Cohen, Seth: 1 article (02/2006)
6. Kaufman, Howard L: 1 article (02/2006)
7. Mitcham, Josephine: 1 article (02/2006)
8. Moroziewicz, Dorota: 1 article (02/2006)
9. Kaufman, H L: 1 article (07/2001)
10. Lee, D: 1 article (07/2001)

Related Diseases

1. Melanoma (Melanoma, Malignant)
2. Infection

Related Drugs and Biologics

1. CD58 Antigens (LFA-3)
2. Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)